Thursday July 27, 2017 07:30

Food and Healthcare Press Releases

Pan Rajdhevee Group Unveils Pan Acne Formula Three Lotion, the Worlds First Acne Solution Innovation, with the #ShockAcneIn3Days Campaign Heathcare—26 Jul 17

Pan Rajdhevee Group, Thailand's leading cosmeceutical brand, pushed forth in continuously developing skincare innovations and introduced "Pan Acne Formula Three Lotion," the ultimate acne solution without relying on any medicine. The solution targets

Do you know new repellent technology INSECT SHIELD was now launched in Thailand Heathcare—21 Jul 17

INSECT SHIELD was developed in USA since 1996 at a request by US Military to terminate Lyme Disease brought by Ticks. As a result of 7 years testing and experiments, now US Army and Marine adopts INSECT SHIELD technology to their uniforms. INSECT SHIELD

ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Heathcare—26 Jul 17

DAWNING study modified to allow patients the opportunity to receive dolutegravir-based regimens ViiV Healthcare, the global specialist HIV company, majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive

Unique concept of MDx, Seegene Random Access System, announced at AACC Heathcare—26 Jul 17

Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the "System") at the 69th AACC Annual Clinical Lab Expo in San Diego, CA, from July

U.S. FDA Determines Celliant(R) Responsive Textile Products Meet Criteria as Medical Devices and Heathcare—25 Jul 17

- Celliant-engineered products clinically proven to promote increased localized blood flow - FDA determination to usher in new era of performance fabrics, responsive textiles Hologenix, LLC, maker of Celliant , the world's most advanced, clinically

PerkinElmer Launches VICTOR(R) Nivo(TM) Multimode Plate Reader Heathcare—25 Jul 17

Multiple Detection Modes and Intuitive Software Help to Simplify and Accelerate Disease Research and Drug Discovery PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced on July 24 (US-time) the launch of its new

EMA#s CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Heathcare—24 Jul 17

- If approved, avelumab could be the first immunotherapy treatment indicated for this rare and aggressive skin cancer in the EU - Decision by the EC is expected in the third quarter of 2017 Merck and Pfizer Inc. (NYSE: PFE) today announced that the

Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting Heathcare—21 Jul 17

- Behind the development of cenegermin are decades of Italian research, stemming from the studies of Rita Levi Montalcini, winner of the Nobel Prize in Medicine for the discovery of the nerve growth factor (NGF). - In 2015, the product was designated as

Global Health Services Company Cigna Acquires Zurich Insurance Middle Heathcare—12 Jul 17

Cigna launches new phase of operations as the premier provider of health and wellness services to Individuals, Employers and Government entities across the Middle East Cigna Corporation (NYSE: CI), a global health services company, today announced the

ALK - Five-year GRAZAX(R) Asthma Prevention (GAP) Trial Reveals Benefits of Early Treatment Heathcare—07 Jul 17

- The disease modifying property of GRAZAX(R) (SQ(R) grass SLIT-tablet) resulted in long-term effect on allergic rhinoconjunctivitis (ARC) and prevented asthma symptoms, even two years after end of treatment in children with grass pollen ARC and no

Merck Awards EUR1.25 Million to Research Projects Through its 2017 Grant for Fertility Innovation Heathcare—05 Jul 17

- The company is committed to driving innovation through evolving the product portfolio and investing in potential breakthrough research Merck, a leading science and technology company, today announced its commitment to award EUR1.25 million to research

UMIT Private University for Health Sciences Medical Informatics and Technology: Results of a Heathcare—04 Jul 17

A simulation study published in BMC Public Health by researchers of the Tyrolean Health and Life Sciences University UMIT, the Oncotyrol center, the Medical University of Innsbruck and the University of Toronto highlights optimized use of prostate cancer

New Analysis Reveals First-Line Treatment Data on SIR-Spheres(R) Y-90 Resin Microspheres for Heathcare—03 Jul 17

SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic colorectal cancer (mCRC) patients with right-sided primary

Novo Nordisk to Present 35 Abstracts at the International Society on Thrombosis and Haemostasis Heathcare—03 Jul 17

Novo Nordisk announced today that data from 35 abstracts will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) congress from 8-13 July, in Germany. This data will be featured across posters, abstracts and oral

Singapore#s Healthcare Leaders will Gather to Realize its Healthcare 2020 Heathcare—27 Jun 17

Singapore and regional healthcare leaders will gather at HIMSS AsiaPac17 from 11 – 14 September at the Marina Bay Sands. Themed Team-Based Care: Unifying Patients and Providers , Guest of Honour Senior Minister of State Chee Hong Tat, Ministry of

Neovii: Long-term Outcomes After Standard Graft-Versus-Host Disease (GvHD) Prophylaxis in Heathcare—26 Jun 17

- The 8-year follow-up results of a randomized phase 3 multicenter trial in adult patients with hematologic malignancies clearly showed more favorable results in the Grafalon(R) group - Severe GvHD-free and relapse-free survival was 34% in the

Wuttisak Groups direction is to indicating to be a beauty and wellness Asias Heathcare—23 Jun 17

Wuttisak Group's direction is to indicating to be a beauty and wellness Asia's leader, expanding by franchise system and there are now morethan 50 prospect franchise units. Wuttisak Group makes the business clearly defined and bring out the strength of

อันฟอร์ส เรย์เซฟ เปิดตัวกล้อง RaySafe Pro-Slit มอบความแม่นยำในการวัดจุดโฟกัส Heathcare—20 Jun 17

อันฟอร์ส เรย์เซฟ (Unfors RaySafe) ผู้นำระดับโลกด้านโซลูชั่นการรับประกันคุณภาพเอกซเรย์ ประกาศเปิดตัวผลิตภัณฑ์ RaySafe Pro-Slit Phantom และ RaySafe Pro-Stand รูปภาพ - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg RaySafe

RaySafe Pro-Slit Camera Provides Accurate Focal Spot Measurement Heathcare—20 Jun 17

Unfors RaySafe, the global leader of X-ray quality assurance solutions introduces the RaySafe Pro-Slit Phantom and the RaySafe Pro-Stand. Photo - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg The RaySafe Pro-Slit Phantom

QIAGEN expands presence in Thailand to serve life sciences Heathcare—16 Jun 17

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced its expansion in Thailand and opened an office in Bangkok to enhance relationships with life science researchers and healthcare providers in the growing market. QIAGEN also announced

Swiss Tech Company Berlinger Special AG to Introduce a New Generation of its Universally-used Heathcare—16 Jun 17

Swiss technology company Berlinger Special AG has developed a totally new generation of the security bottles which it supplies for anti-doping testing worldwide over the past few months. The new "BEREG-KIT Geneva" security bottles are currently being

LEO Pharma Starts Phase 3 Clinical Study for Tralokinumab in Atopic Heathcare—15 Jun 17

LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically targets the cytokine IL-13[1], which plays an important role in

Merck Awarded its First CRISPR Patent by Australian Patent Office Heathcare—15 Jun 17

- Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR - Similar patents pending in other countries; anticipate favorable outcomes , a leading science and technology company, today

Croma-Pharma Announces Two Major Milestones in China Heathcare—14 Jun 17

- Austria-based Croma-Pharma forms Joint Venture with Sihuan Pharmaceutical to market premium Intradermal-Filler in China, Hong Kong and Macao The registration of Princess(R) VOLUME and the signed Joint Venture open the fastest growing market for